Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSV-Reference-Cited by-同舟云学术

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia—RSV recombinants or RSV

Published:1992-01 Issue:7 Volume:10 Page:475-484
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Connors Mark,Collins Peter L.,Firestone Cai-Yen,Sotnikov Alex V.,Waitze Alan,Davis Alan R.,Hung Paul P.,Chanock Robert M.,Murphy Brian R.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus;Kim;Pediatrics,1971

2. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children;Kim;Pediatrics,1973

3. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population;Chin;Am. J. Epidemiol.,1969

4. Respiratory Virus Immunization;Fulginiti,1969

5. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine;Kim;Am. J. Epidemiol.,1969

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus;Viruses;2024-05-24

2. Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters;PLOS Pathogens;2024-05-13

3. Value profile for respiratory syncytial virus vaccines and monoclonal antibodies;Vaccine;2023-11

4. Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge;Vaccines;2022-12-05

5. Protective antigenic sites identified in respiratory syncytial virus fusion protein reveals importance of p27 domain;EMBO Molecular Medicine;2021-11-08